Send the following on WhatsApp
Continue to ChatEMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease on Labiotech.eu https://www.labiotech.eu/trends-news/ema-maa-lecanemab-early-alzheimers-disease/
EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease on Labiotech.eu https://www.labiotech.eu/trends-news/ema-maa-lecanemab-early-alzheimers-disease/